Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 248 entries
View as:

Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.

Phase: N/A Priority: Normal
NCT ID: NCT02234089 Org: User:
Start: 09/30/14 End: 06/30/19 Due: 06/30/20

An Open-label Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at Term

Phase: N/A Priority: Normal
NCT ID: NCT03067597 Org: User:
Start: 02/22/17 End: 02/24/18 Due: 02/24/19

Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)

Phase: N/A Priority: Normal
NCT ID: NCT04329975 Org: User:
Start: 05/19/20 End: 09/25/24 Due: 09/25/25

Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia

Phase: N/A Priority: Normal
NCT ID: NCT00477490 Org: User:
Start: 05/31/07 End: 02/29/08 Due: 02/28/09

Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03274973 Org: User:
Start: 05/14/18 End: 10/31/18 Due: 10/31/19

Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00884273 Org: User:
Start: 08/31/09 End: 03/31/11 Due: 03/31/12

A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women

Phase: N/A Priority: Normal
NCT ID: NCT04902131 Org: User:
Start: 11/02/21 End: 08/15/22 Due: 08/15/23

Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist

Phase: N/A Priority: Normal
NCT ID: NCT01331733 Org: User:
Start: 11/30/06 End: 03/31/09 Due: 03/31/10

Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01184859 Org: User:
Start: 07/31/10 End: 04/30/11 Due: 04/30/12

Effectiveness of Cortiment® in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT02586259 Org: User:
Start: 12/31/15 End: 04/05/18 Due: 04/05/19

A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease

Phase: N/A Priority: Normal
NCT ID: NCT02790281 Org: User:
Start: 12/31/14 End: 08/31/15 Due: 08/31/16

A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.

Phase: N/A Priority: Normal
NCT ID: NCT03564509 Org: User:
Start: 05/14/18 End: 01/08/20 Due: 01/08/21

A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT01280981 Org: User:
Start: 04/30/07 End: 05/31/09 Due: 05/31/10

Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour

Phase: N/A Priority: Normal
NCT ID: NCT00346840 Org: User:
Start: 06/30/03 End: 03/31/04 Due: 03/31/05

Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device

Phase: N/A Priority: Normal
NCT ID: NCT01306357 Org: User:
Start: 09/30/07 End: 11/30/11 Due: 11/30/12

A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02726009 Org: User:
Start: 05/31/16 End: 05/15/20 Due: 05/15/21

Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects with High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)

Phase: N/A Priority: Normal
NCT ID: NCT05704244 Org: User:
Start: 12/21/22 End: 09/30/29 Due: 09/30/30

Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)

Phase: N/A Priority: Normal
NCT ID: NCT00950105 Org: User:
Start: 07/31/09 End: 10/31/09 Due: 10/31/10

Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.

Phase: N/A Priority: Normal
NCT ID: NCT00737789 Org: User:
Start: 11/30/08 End: 06/30/10 Due: 06/30/11

Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females

Phase: N/A Priority: Normal
NCT ID: NCT00796289 Org: User:
Start: 02/28/09 End: 01/31/10 Due: 01/31/11

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06545955 Org: User:
Start: 10/01/24 End: 12/31/30 Due: 12/31/31

Elobixibat Colonic Motor Function Study

Phase: N/A Priority: Normal
NCT ID: NCT02392546 Org: User:
Start: 04/30/15 End: 04/30/16 Due: 04/30/17

A Phase III Study With FE 999169 Versus Niflec for Colon Cleansing

Phase: N/A Priority: Normal
NCT ID: NCT02215954 Org: User:
Start: 09/30/14 End: 12/31/14 Due: 12/31/15

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02905682 Org: User:
Start: 09/30/16 End: 09/27/17 Due: 09/27/18

Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00215657 Org: User:
Start: 03/31/03 End: 03/31/06 Due: 03/31/07